Physician
Gealow, Mary
Gealow, Mary was paid $1.63M by Medicaid between Jan 2018 and Mar 2023, across 36 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 25% of everything it billed.
33Billing provider infoGEALOW, MARY
LOWELL, MA 01852
LOWELL, MA 01852
33aNPI1679536379assigned 04/11/2006
33bProvider typePediatrics Physician
28Total paid$1.63M
24GClaims42,947
24DCodes billed36
24AFirst – last monthJan 2018 – Mar 2023
Compared with peers
Next to other Pediatrics Physician providers in Massachusetts
Rank by total paid#39 of 1,273
Median peer was paid$24K
This provider vs. median68×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,703 | $300K | |
| 2019 | 8,692 | $307K | |
| 2020 | 6,914 | $247K | |
| 2021 | 7,778 | $291K | |
| 2022 | 10,007 | $406K | |
| 2023 | 1,853 | $78K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 25% | 7,058 | 6,800 | $406K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 3,273 | 3,164 | $302K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 9.2% | 3,672 | 3,657 | $151K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.7% | 1,365 | 1,365 | $110K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.6% | 1,040 | 1,040 | $91K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.1% | 1,010 | 1,010 | $83K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.7% | 1,498 | 1,475 | $77K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3.2% | 646 | 637 | $53K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.1% | 668 | 662 | $51K |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | 2.4% | 4,394 | 4,391 | $40K |
| 90461 | 2.4% | 1,029 | 1,028 | $38K | |
| 92558 | 1.9% | 1,277 | 1,276 | $31K |
24 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.7% | 2,622 | $27K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 1,038 | $25K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.5% | 765 | $24K |
| 96127 | 1.3% | 2,009 | $21K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 1,361 | $18K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,027 | $13K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 598 | $10K |
| 99173 | <1% | 599 | $9K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 89 | $9K |
| 99177 | <1% | 544 | $7K | |
| 87081 | <1% | 1,013 | $7K | |
| 83655 | <1% | 598 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 887 | $7K |
| 94760 | <1% | 2,210 | $5K | |
| 36416 | <1% | 391 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 41 | $2K |
| 87634 | <1% | 15 | $928.80 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 24 | $705.38 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 24 | $705.38 |
| 0072A | <1% | 12 | $550.56 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 30 | $457.80 |
| 92587 | <1% | 12 | $202.68 | |
| 81003 | <1% | 80 | $169.50 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 28 | $7.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.